Loading
Chronic Obstructive Pulmonary Disease (COPD) Research / Asthma and Respiratory Diseases / Adipokines, Inflammation, and Metabolic Diseases · Review
International Journal of Innovative Technologies in Social Science · September 10, 2026
A consensus or society position rather than new primary data.
This systematic review identifies obesity-related chronic low-grade inflammation, adipokine dysregulation, and immune dysfunction as central mechanisms linking obesity to asthma pathogenesis and severity in adults. The review concludes that obesity-related asthma is a heterogeneous entity involving overlapping inflammatory, metabolic, mechanical, and behavioral pathways, and recommends clinical management extending beyond inhaled pharmacotherapy to include weight management and comorbidity screening. No quantitative meta-analysis or new primary efficacy data are presented.
Systematic review. Literature on obesity and asthma in adults; inclusion criteria for studies not fully specified..
Obesity-related asthma involves multiple overlapping inflammatory, metabolic, mechanical, and behavioral pathways rather than a single uniform phenotype. Increased systemic inflammatory activity, altered leptin and adiponectin signaling, elevated interleukin-6, and neutrophilic airway inflammation are implicated in worse asthma control. Comorbidities including obstructive sleep apnea and gastroesophageal reflux contribute to asthma severity in adults with obesity.
Clinical management recommendations extend beyond inhaled pharmacotherapy to include obesity assessment, weight management, comorbidity screening, lifestyle intervention, and inflammatory phenotype evaluation.
Clinicians should recognize obesity-related asthma as a heterogeneous condition driven by inflammation and metabolic dysfunction, and adopt a multidisciplinary management approach that includes weight management and comorbidity screening alongside conventional asthma pharmacotherapy. This review identifies gaps in evidence and suggests that future research should clarify which interventions most effectively improve outcomes in this population.
A systematic review synthesizing mechanistic and clinical evidence on obesity-related asthma pathogenesis, offering clinical management recommendations but not reporting new primary data or effect sizes.
As stated by the source record.
Clinicians should recognize obesity-related asthma as a heterogeneous condition driven by inflammation and metabolic dysfunction, and adopt a multidisciplinary management approach that includes weight management and comorbidity screening alongside conventional asthma pharmacotherapy. This review identifies gaps in evidence and suggests that future research should clarify which interventions most effectively improve outcomes in this population.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
What is missing. This record has no reported figures. That is a gap in the analysis, not a judgement about the study.
Obesity and asthma are common chronic conditions that frequently coexist in adults and contribute to a substantial clinical and public health burden. Although excess body weight affects asthma through mechanical effects on lung volumes and airway closure, current evidence increasingly supports the role of obesity-related chronic low-grade inflammation as a central mechanism linking obesity with asthma development, severity, symptom burden, exacerbation risk, and therapeutic response. This systematic review summarizes contemporary evidence on the role of adipose-tissue inflammation, adipokines, cytokine signaling, metabolic dysfunction, oxidative stress, and immune dysregulation in the pathogenesis and clinical expression of obesity-related asthma in adults. A structured literature search was performed using major biomedical databases, with priority given to systematic reviews, meta-analyses, clinical reviews, cohort studies, mechanistic studies, and current asthma guidelines. The available literature indicates that obesity-related asthma is not a single uniform phenotype but a heterogeneous clinical entity involving overlapping inflammatory, metabolic, mechanical, and behavioral pathways. Increased systemic inflammatory activity, altered leptin and adiponectin signaling, elevated interleukin-6, neutrophilic airway inflammation, insulin resistance, and comorbidities such as obstructive sleep apnea and gastroesophageal reflux may all contribute to worse asthma control. Clinical management should therefore extend beyond inhaled pharmacotherapy and include assessment of obesity as a treatable trait, weight management, comorbidity screening, lifestyle intervention, and individualized evaluation of inflammatory phenotype. Future studies should clarify causal mechanisms and determine which interventions most effectively improve asthma outcomes in adults with obesity.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.